Polyzene®-F (patient information)

Quick Start: You don't need to be Editor-In-Chief to add or edit content. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Overview
Although the debate over stent usage has until now centered on the merits of bare-metal versus drug-eluting stents, new research shows that there may be a novel alternative approach to stenting which offers all the benefits of a drug-eluting device with none of the drawbacks: stents treated with a nanothin layer of Polyzene®-F. Polyzene®-F, patented by CeloNova BioSciences, Inc., is an inert surface treatment which prevents inflammation and platelet adhesion while promoting rapid, healthy endothelial cell growth and vessel healing. As a result, a stent treated with Polyzene®-F inhibits both restenosis and thrombus formation without the need to resort to an anti-proliferative drug and potentially indefinite dual antiplatelet therapy.